Journal Article

Patient and provider experiences with active surveillance: A scoping review

Wright, Frances C., Groot, Gary, Helyer, Lucy, Quan, May Lynn, Kim, Claire, Gagliardi, Anna R., Look Hong, Nicole J., Warburton, Rebecca, Urquhart, Robin, Meiers, Pamela

2018

Overview

Active surveillance (AS) represents a fundamental shift in managing select cancer patients that initiates treatment only upon disease progression to avoid overtreatment. Given uncertain outcomes, patient engagement could support decision-making about AS. Little is known about how to optimize patient engagement for AS decision-making. This scoping review aimed to characterize research on patient and provider communication about AS, and associated determinants and outcomes. MEDLINE, EMBASE, CINAHL, and The Cochrane Library were searched from 2006 to October 2016. English language studies that evaluated cancer patient or provider AS views, experiences or behavioural interventions were eligible. Screening and data extraction were done in duplicate. Summary statistics were used to describe study characteristics and findings. A total of 2,078 studies were identified, 1,587 were unique, and 1,243 were excluded based on titles/abstracts. Among 344 full-text articles, 73 studies were eligible: 2 ductal carcinoma in situ (DCIS), 4 chronic lymphocytic leukemia (CLL), 6 renal cell carcinoma (RCC) and 61 prostate cancer. The most influential determinant of initiating AS was physician recommendation. Others included higher socioeconomic status, smaller tumor size, comorbid disease, older age, and preference to avoid adverse treatment effects. AS patients desired more information about AS and reassurance about future treatment options, involvement in decision-making and assessment of illness uncertainty and supportive care needs during follow-up. Only three studies of prostate cancer evaluated interventions to improve AS communication or experience. This study revealed a paucity of research on AS communication for DCIS, RCC and CLL, but generated insight on how to optimize AS discussions in the context of routine care or clinical trials from research on AS for prostate cancer. Further research is needed on AS for patients with DCIS, RCC and CLL, and to evaluate interventions aimed at patients and/or providers to improve AS communication, experience and associated outcomes.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Biology and Life Sciences / Breast cancer / Cancer / Chronic lymphocytic leukemia / Clinical decision making / Clinical trials / Communication / Decision making / Disease control / Disease Progression / English language / Health attitudes / Health care networks / Health sciences / Humans / Kidney cancer / Leukemia / Lymphatic leukemia / Medical communication / Medical research / Medical treatment / Medicine and Health Sciences / Mens health / Neoplasms - physiopathology / Neoplasms - therapy / Patients / People and Places / Preferences / Prostate cancer / Quality of life / Renal cell carcinoma / Sentinel surveillance / Social Sciences / Socioeconomics / Studies / Surgery / Surveillance / Surveys / Systematic review / Urology